MannKind (MNKD) Competitors

MannKind (NASDAQ:MNKD) and Alkermes (NASDAQ:ALKS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, community ranking, media sentiment and institutional ownership.

Does the media prefer MNKD or ALKS?

In the previous week, Alkermes had 14 more articles in the media than MannKind. MarketBeat recorded 18 mentions for Alkermes and 4 mentions for MannKind. Alkermes' average media sentiment score of 1.20 beat MannKind's score of 0.85 indicating that Alkermes is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MannKind	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alkermes	12 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate MNKD or ALKS?

MannKind presently has a consensus target price of $9.21, suggesting a potential upside of 80.67%. Alkermes has a consensus target price of $39.38, suggesting a potential upside of 17.46%. Given MannKind's stronger consensus rating and higher possible upside, equities research analysts plainly believe MannKind is more favorable than Alkermes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MannKind	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.13
Alkermes	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.69

Which has more volatility and risk, MNKD or ALKS?

MannKind has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, Alkermes has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500.

Is MNKD or ALKS more profitable?

Alkermes has a net margin of 23.57% compared to MannKind's net margin of 8.07%. Alkermes' return on equity of 30.80% beat MannKind's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MannKind	8.07%	-17.74%	8.68%
Alkermes	23.57%	30.80%	19.09%

Which has stronger valuation & earnings, MNKD or ALKS?

Alkermes has higher revenue and earnings than MannKind. Alkermes is trading at a lower price-to-earnings ratio than MannKind, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MannKind	$285.50M	5.42	-$11.94M	$0.10	51.00
Alkermes	$1.56B	3.50	$367.07M	$2.17	15.45

Do insiders and institutionals hold more shares of MNKD or ALKS?

49.5% of MannKind shares are owned by institutional investors. Comparatively, 95.2% of Alkermes shares are owned by institutional investors. 3.0% of MannKind shares are owned by company insiders. Comparatively, 4.9% of Alkermes shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer MNKD or ALKS?

Alkermes received 115 more outperform votes than MannKind when rated by MarketBeat users. Likewise, 70.41% of users gave Alkermes an outperform vote while only 60.33% of users gave MannKind an outperform vote.

Company	Underperform	Outperform
MannKind	Outperform Votes 587 60.33%	Underperform Votes 386 39.67%
Alkermes	Outperform Votes 702 70.41%	Underperform Votes 295 29.59%

Summary

Alkermes beats MannKind on 13 of the 19 factors compared between the two stocks.